Q301 - Thyro Seq v3 Genomic Classifier (GC) Testing
Contract Opportunity Analysis
The Department of Veterans Affairs, Network Contracting Office 10, intends to negotiate a sole source contract for the ThyroSeq v3 Genomic Classifier (GC) testing services, which are critical for molecular diagnostic testing at the VA Northeast Ohio Healthcare System. The contract will be awarded to Cytopath Biopsy Lab Inc., the exclusive provider of this proprietary molecular assay in the United States, as it is believed to be the only source capable of fulfilling the agency's requirements. This testing service is essential for accurate diagnosis and treatment planning in patients with thyroid conditions. Interested parties may submit capability statements to Thomas Bellamy at Thomas.Bellamy@va.gov by 3:00 p.m. EST on November 12, 2025, although this notice is not a solicitation for competitive proposals.